 |
Osstem Implant (photo by Yonhap News) |
[Alpha Biz= Reporter Kim Sangjin] Osstem Implant announced on the 11th that it will merge with its subsidiary, Topplan, which develops and manufactures implants. The merger is set to take place on January 1 next year. Osstem Implant, the surviving company, will hold 100% of Topplan's shares, and since the surviving company will not issue new shares of the dissolving company, the merger ratio has been set at 1:0. Osstem Implant's board of directors approved the merger plan on the 29th of last month.
Topplan was established in January 2017 and has been targeting the market by launching various implant products in collaboration with Osstem Implant's research institute. The company plans to develop a separate business division within Osstem Implant, with all existing employees being retained, and will aim to explore the market under its own brand.
AlphaBIZ Kim SangJin(letyou@alphabiz.co.kr)
